This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 510 |
| GenV | 194 |
| Health | 124 |
| SARS | 114 |
| Clinical | 103 |
| Phase | 91 |
| Fig | 90 |
| • | 89 |
| Trials | 79 |
| CoV-2 | 77 |
| China | 77 |
| COPD | 76 |
| Table | 73 |
| Research | 72 |
| IT | 70 |
| iPad | 67 |
| Data | 64 |
| RCT | 63 |
| RCTs | 63 |
| Trial | 60 |
| CI | 59 |
| meta | 55 |
| US | 54 |
| United | 52 |
| Committee | 50 |
| FDA | 49 |
| Coronavirus | 47 |
| March | 46 |
| University | 46 |
| National | 46 |
| TCM | 45 |
| States | 45 |
| International | 45 |
| sha | 44 |
| II | 42 |
| ClinicalTrials.gov | 42 |
| World | 41 |
| Medical | 41 |
| remdesivir | 41 |
| Korea | 38 |
| Hydroxychloroquine | 38 |
| hydroxychloroquine | 37 |
| Group | 37 |
| DOI | 37 |
| MERS | 36 |
| April | 36 |
| Meta | 35 |
| Organization | 35 |
| European | 34 |
| ICU | 32 |
| Drug | 31 |
| ARDS | 31 |
| Wuhan | 30 |
| NAIROS | 30 |
| J | 30 |
| GCP | 30 |
| Treatment | 29 |
| UK | 29 |
| ritonavir | 28 |
| Disease | 28 |
| Covid-19 | 28 |
| Agency | 28 |
| mg | 28 |
| Efficacy | 27 |
| Protection | 26 |
| C | 26 |
| Hospital | 26 |
| Safety | 26 |
| Remdesivir | 26 |
| Study | 26 |
| azithromycin | 26 |
| Use | 25 |
| ICH | 25 |
| Care | 25 |
| Administration | 25 |
| Ebola | 24 |
| AEs | 24 |
| Food | 24 |
| Medicines | 24 |
| Society | 24 |
| Norway | 23 |
| June | 23 |
| Cochrane | 23 |
| COVID | 23 |
| Analysis | 23 |
| Hopper | 22 |
| Cancer | 22 |
| WHO | 22 |
| Review | 22 |
| lopinavir | 22 |
| Ethics | 21 |
| A | 21 |
| Chloroquine | 21 |
| Council | 21 |
| EU | 21 |
| DARIS | 21 |
| Human | 21 |
| Italy | 21 |
| Science | 21 |
| Victoria | 21 |
| multicentre | 21 |
| LIVE@Home | 20 |
| DMC | 20 |
| Europe | 20 |
| Institute | 20 |
| May | 20 |
| NIH | 20 |
| Network | 20 |
| nan | 20 |
| Medicine | 19 |
| Jacobson | 19 |
| Azithromycin | 19 |
| Assessment | 19 |
| IRB | 18 |
| Effect | 18 |
| Good | 18 |
| Madagascar | 18 |
| Pandemic | 18 |
| M. | 18 |
| Monitoring | 18 |
| Manis | 18 |
| Registry | 17 |
| Practice | 17 |
| M | 17 |
| ICTRP | 17 |
| EMA | 17 |
| Dementia | 17 |
| Conservation | 17 |
| Board | 17 |
| Act | 17 |
| Directive | 16 |
| CC | 16 |
| CONSORT | 16 |
| Conference | 16 |
| F | 16 |
| East | 16 |
| HIV | 16 |
| NHS | 16 |
| RR | 16 |
| Sunda | 15 |
| Norwegian | 15 |
| Journal | 15 |
| January | 15 |
| General | 15 |
| France | 15 |
| Africa | 15 |
| Chinese | 14 |
| February | 14 |
| Development | 14 |
| July | 14 |
| Centre | 14 |
| Association | 14 |
| AE | 14 |
| III | 14 |
| Management | 14 |
| Middle | 14 |
| Nature | 14 |
| Peter | 14 |
| Report | 14 |
| S3 | 14 |
| SD | 14 |
| Spain | 14 |
| ITT | 13 |
| A. | 13 |
| Asia | 13 |
| CoV | 13 |
| December | 13 |
| Figure | 13 |
| IPM | 13 |
| Evaluation | 13 |
| PNIF | 13 |
| Patients | 13 |
| RSV | 13 |
| Respiratory | 13 |
| Risk | 13 |
| Syndrome | 13 |
| USA | 13 |
| New | 13 |
| Control | 12 |
| ID | 12 |
| Dr. | 12 |
| D21 | 12 |
| D11 | 12 |
| Creative | 12 |
| Commons | 12 |
| Australia | 12 |
| Appendix | 12 |
| ALI | 12 |
| AC | 12 |
| JWBY | 12 |
| IQR | 12 |
| Patient | 12 |
| MAR | 12 |
| Springer | 12 |
| prednisone | 12 |
| NPR | 12 |
| kg | 12 |
| Working | 12 |
| Technology | 12 |
| methotrexate | 12 |
| Sciences | 12 |
| PICU | 12 |
| Oxford | 12 |
| North | 12 |
| Lancet | 11 |
| 4-year | 11 |
| BMJ | 11 |
| Bergen | 11 |
| CRF | 11 |
| Department | 11 |
| GenV. | 11 |
| Generation | 11 |
| Guidance | 11 |
| IV | 11 |
| Information | 11 |
| COVID19 | 11 |
| Lopinavir | 11 |
| Steering | 11 |
| MCAR | 11 |
| committee | 11 |
| _ | 11 |
| Zika | 11 |
| www.nature.com/scientificreports/ | 11 |
| Statistical | 11 |
| S1 | 11 |
| RDT | 11 |
| QRI | 11 |
| Public | 11 |
| August | 10 |
| Clin | 10 |
| England | 10 |
| KCDC | 10 |
| Foundation | 10 |
| Harmonisation | 10 |
| Helsinki | 10 |
| Innovation | 10 |
| Institutional | 10 |
| Intent | 10 |
| J. | 10 |
| TNF | 10 |
| Med | 10 |
| Supplementary | 10 |
| Michael | 10 |
| ciprofloxacin | 10 |
| Time | 10 |
| Systematic | 10 |
| TRK | 10 |
| South | 10 |
| Products | 10 |
| Platform | 10 |
| Plan | 10 |
| HPA | 9 |
| Kingdom | 9 |
| Institutes | 9 |
| Impact | 9 |
| IL-23 | 9 |
| I(2 | 9 |
| Alzheimer | 9 |
| H. | 9 |
| EC | 9 |
| Director | 9 |
| DSMB | 9 |
| B | 9 |
| Al | 9 |
| Note | 9 |
| PRISMA | 9 |
| Prevention | 9 |
| Septoplasty | 9 |
| © | 9 |
| Pro | 9 |
| interferon | 9 |
| favipiravir | 9 |
| apremilast | 9 |
| Sun | 9 |
| medRxiv | 9 |
| Schmitz | 9 |
| S6 | 9 |
| Randomized | 9 |
| RA | 9 |
| Project | 9 |
| SAP | 9 |
| Lung | 8 |
| IL-6 | 8 |
| Inc. | 8 |
| Infection | 8 |
| Interventions | 8 |
| Ministry | 8 |
| MEDLINE | 8 |
| Master | 8 |
| Model | 8 |
| Nasal | 8 |
| I | 8 |
| IL-17 | 8 |
| Novel | 8 |
| Huashan | 8 |
| GTM | 8 |
| Fisher | 8 |
| Federal | 8 |
| Experimenter | 8 |
| D. | 8 |
| Chi | 8 |
| Center | 8 |
| CRP | 8 |
| Belmont | 8 |
| BE | 8 |
| 8) | 8 |
| Netherlands | 8 |
| ECG | 8 |
| Oncology | 8 |
| S5 | 8 |
| Open | 8 |
| dexamethasone | 8 |
| Y. | 8 |
| Wei | 8 |
| Southeast | 8 |
| Scientific | 8 |
| Scale | 8 |
| α | 8 |
| Saudi | 8 |
| Salk | 8 |
| SPIRIT | 8 |
| SNOT-22 | 8 |
| mofetil | 8 |
| S4 | 8 |
| RUD | 8 |
| Ritonavir | 8 |
| Protocol | 8 |
| PubMed | 8 |
| R | 8 |
| Pan | 8 |
| Recommendations | 8 |
| Regulatory | 8 |
| Reporting | 8 |
| Reviews | 8 |
| Regulation | 8 |
| Guideline | 7 |
| David | 7 |
| Declaration | 7 |
| Effectiveness | 7 |
| Glaser | 7 |
| Healthcare | 7 |
| Harriett | 7 |
| IMP | 7 |
| Influenza | 7 |
| College | 7 |
| Iran | 7 |
| Critical | 7 |
| COVID‐19 | 7 |
| Collaboration | 7 |
| Chronic | 7 |
| Children | 7 |
| Chen | 7 |
| CSM | 7 |
| CD20 | 7 |
| B11 | 7 |
| Advisory | 7 |
| Adults | 7 |
| Acute | 7 |
| Access | 7 |
| K | 7 |
| John | 7 |
| Intervention | 7 |
| Kluwer | 7 |
| Solidarity | 7 |
| MFDS | 7 |
| β1b | 7 |
| https://doi.org/10 | 7 |
| Wolters | 7 |
| West | 7 |
| Vaccine | 7 |
| Urquhart | 7 |
| Union | 7 |
| Theory | 7 |
| Test | 7 |
| TMG | 7 |
| Subjects | 7 |
| Unit | 7 |
| School | 7 |
| PPI | 7 |
| Mashhad | 7 |
| SAEs | 7 |
| N95 | 7 |
| ORCHID | 7 |
| P. | 7 |
| Outcomes | 7 |
| Principles | 7 |
| Prophylaxis | 7 |
| Questionnaire | 7 |
| S2 | 7 |
| GDPR | 6 |
| Initiative | 6 |
| Hib | 6 |
| Hospitalised | 6 |
| Huang | 6 |
| ICT | 6 |
| IPTp | 6 |
| L | 6 |
| Jens | 6 |
| Jensen | 6 |
| Joshua | 6 |
| K. | 6 |
| London | 6 |
| MD | 6 |
| Expert | 6 |
| Form | 6 |
| Apremilast | 6 |
| Embase | 6 |
| Beaudry | 6 |
| NOSE | 6 |
| -Preliminary | 6 |
| America | 6 |
| Arabia | 6 |
| BY | 6 |
| Bagayogo | 6 |
| Bradford | 6 |
| Elizabeth | 6 |
| Bushen | 6 |
| Central | 6 |
| Clark | 6 |
| Commission | 6 |
| Danish | 6 |
| Design | 6 |
| MIRACLE | 6 |
| S7 | 6 |
| Novartis | 6 |
| Supplemental | 6 |
| U.S. | 6 |
| Ulrik | 6 |
| Utilization | 6 |
| W | 6 |
| Workshop | 6 |
| Yiqi | 6 |
| Zelazo | 6 |
| alpha-2b | 6 |
| biosimilar | 6 |
| etanercept | 6 |
| mycophenolate | 6 |
| pemphigus | 6 |
| tocilizumab | 6 |
| ORR | 6 |
| | | 6 |
| TOC | 6 |
| homophily | 6 |
| Studies | 6 |
| Quality | 6 |
| PageRank | 6 |
| Statement | 6 |
| PFS | 6 |
| Pangolins | 6 |
| Proactive | 6 |
| Province | 6 |
| Pharmaceutical | 6 |
| RRR | 6 |
| State | 6 |
| Russ | 6 |
| S | 6 |
| Sarah | 6 |
| Registration | 6 |
| Government | 5 |
| Hub | 5 |
| Home | 5 |
| Harmonization | 5 |
| Garry | 5 |
| Global | 5 |
| GMO | 5 |
| Forum | 5 |
| Executive | 5 |
| IL-12 | 5 |
| Ferneley | 5 |
| ICMJE | 5 |
| Kong | 5 |
| IgM | 5 |
| India | 5 |
| Investigators | 5 |
| Italian | 5 |
| Johnson | 5 |
| Kristiansand | 5 |
| Life | 5 |
| MMSE | 5 |
| Medline | 5 |
| Missing | 5 |
| NC | 5 |
| Empowerment | 5 |
| NCTU | 5 |
| Estimands | 5 |
| CSB | 5 |
| ELISA | 5 |
| CT | 5 |
| OS | 5 |
| < | 5 |
| ADL | 5 |
| AT | 5 |
| Ahuja | 5 |
| American | 5 |
| B99 | 5 |
| Baerum | 5 |
| Boards | 5 |
| C. | 5 |
| CFR | 5 |
| CTR | 5 |
| Dermatology | 5 |
| CVD | 5 |
| California | 5 |
| Case | 5 |
| Ciborra | 5 |
| Code | 5 |
| Cohen | 5 |
| Cohorts | 5 |
| Criteria | 5 |
| D | 5 |
| Davis | 5 |
| Denmark | 5 |
| NSCLC | 5 |
| Thatcher | 5 |
| Office | 5 |
| bivalirudin | 5 |
| Thailand | 5 |
| Trade | 5 |
| Trust | 5 |
| User | 5 |
| Video | 5 |
| Vietnam | 5 |
| Wales | 5 |
| Whiten | 5 |
| Wu | 5 |
| Zamani | 5 |
| ant | 5 |
| chloroquine | 5 |
| Surg | 5 |
| doc_id | 5 |
| http:// | 5 |
| iPhone | 5 |
| malaria | 5 |
| of-1 | 5 |
| s13063 | 5 |
| stay | 5 |
| steering | 5 |
| β-1a | 5 |
| κB | 5 |
| P | 5 |
| TRIN | 5 |
| rhesus | 5 |
| Stress | 5 |
| Regional | 5 |
| PCR | 5 |
| Sterimar | 5 |
| PE | 5 |
| PI | 5 |
| Pinsonneault | 5 |
| Policy | 5 |
| Proceedings | 5 |
| Proportion | 5 |
| Pulmonary | 5 |
| RSS | 5 |
| Randomised | 5 |
| Pharmaceuticals | 5 |
| Resource | 5 |
| Services | 5 |
| S8 | 5 |
| Standards | 5 |
| Social | 5 |
| Shen | 5 |
| Sobreperez | 5 |
| Scopus | 5 |
| Sanofi | 5 |
| SDD | 5 |
| SAE | 5 |
| Spray | 5 |
| HemOnc.org | 4 |
| HeLTI | 4 |
| GP | 4 |
| Handbook | 4 |
| Gupta | 4 |
| Guide | 4 |
| Groups | 4 |
| 4 | |
| Gautret | 4 |
| F. | 4 |
| Frye | 4 |
| Forecast | 4 |
| Fidock | 4 |
| FDAAA | 4 |
| EudraCT | 4 |
| Editorial | 4 |
| Early | 4 |
| EV | 4 |
| I. | 4 |
| E9 | 4 |
| Hubei | 4 |
| L. | 4 |
| INR | 4 |
| LMST | 4 |
| Dr | 4 |
| N | 4 |
| Melissa | 4 |
| Matthew | 4 |
| Marie | 4 |
| Mann | 4 |
| MNAR | 4 |
| Li | 4 |
| Jia | 4 |
| ITI | 4 |
| Japan | 4 |
| Items | 4 |
| Inventory | 4 |
| Integrative | 4 |
| Int | 4 |
| Informed | 4 |
| Imputation | 4 |
| IgG | 4 |
| E | 4 |
| Background | 4 |
| Diseases | 4 |
| Amgen | 4 |
| Bautista | 4 |
| Barki | 4 |
| B23 | 4 |
| Azathioprine | 4 |
| Authority | 4 |
| Attribution | 4 |
| AstraZeneca | 4 |
| Andrew | 4 |
| Americas | 4 |
| Boehringer | 4 |
| Alliance | 4 |
| Ageing | 4 |
| Adaptive | 4 |
| Action | 4 |
| AR | 4 |
| ACC | 4 |
| 4,3,2,1 | 4 |
| NIHR | 4 |
| Blood | 4 |
| Box | 4 |
| Difference | 4 |
| Christian | 4 |
| DeSanctis | 4 |
| Dale | 4 |
| Cox | 4 |
| Comparative | 4 |
| Common | 4 |
| Combination | 4 |
| Co | 4 |
| Ciprofloxacin | 4 |
| Chicago | 4 |
| Breakthrough | 4 |
| ChiCTR | 4 |
| Characteristics | 4 |
| Centers | 4 |
| Carroll | 4 |
| CVD103-HgR | 4 |
| CTCAE | 4 |
| CPL | 4 |
| Brosnan | 4 |
| NCT | 4 |
| Dis | 4 |
| Nielsen | 4 |
| Systems | 4 |
| Wood | 4 |
| Women | 4 |
| Whitney | 4 |
| Western | 4 |
| Washington | 4 |
| Version | 4 |
| Venkatesh | 4 |
| VN | 4 |
| VEK | 4 |
| URTI | 4 |
| Truog | 4 |
| Treatments | 4 |
| Therapy | 4 |
| Therapies | 4 |
| Thalidomide | 4 |
| Team | 4 |
| Tang | 4 |
| TSC | 4 |
| T | 4 |
| X | 4 |
| Yang | 4 |
| Zealand | 4 |
| max | 4 |
| November | 4 |
| yellow | 4 |
| ward | 4 |
| qPCR | 4 |
| pyrimethamine | 4 |
| org/ | 4 |
| nonresearch | 4 |
| monitoring | 4 |
| latency | 4 |
| Zelen | 4 |
| keytruda | 4 |
| k0 | 4 |
| https | 4 |
| gentamicin | 4 |
| disease | 4 |
| dihydroartemisinin | 4 |
| darunavir | 4 |
| Zheng | 4 |
| ± | 4 |
| oseltamivir | 4 |
| System | 4 |
| Pope | 4 |
| Qualitative | 4 |
| Qin | 4 |
| Qi | 4 |
| Q | 4 |
| Publisher | 4 |
| Program | 4 |
| Preferred | 4 |
| Pradeesh | 4 |
| Poole | 4 |
| RSI | 4 |
| Poisson | 4 |
| Pluto | 4 |
| Pharmacologic | 4 |
| Personal | 4 |
| Pediatric | 4 |
| PICF | 4 |
| Survival | 4 |
| Oslo | 4 |
| R. | 4 |
| PWD | 4 |
| Recruitment | 4 |
| Sabin | 4 |
| Surgery | 4 |
| RedCap | 4 |
| Shao | 4 |
| Shanghai | 4 |
| September | 4 |
| Seoul | 4 |
| Scutellaria | 4 |
| San | 4 |
| Singh | 4 |
| SIV | 4 |
| Reports | 4 |
| Regeneron | 4 |
| Register | 4 |
| SF-36 | 4 |
| Sivapalan | 4 |
| Republic | 4 |
| SARs | 4 |
| Rubin | 4 |
| George | 3 |
| G | 3 |
| G. | 3 |
| GEE | 3 |
| GLM | 3 |
| GLMM | 3 |
| Gentofte | 3 |
| Germany | 3 |
| Grounded | 3 |
| Gibson | 3 |
| Gilead | 3 |
| Guinea | 3 |
| Gopnik | 3 |
| Gordon | 3 |
| Grants | 3 |
| GraphPad | 3 |
| Front | 3 |
| GlaxoSmithKline | 3 |
| Facemasks | 3 |
| French | 3 |
| Exosurf | 3 |
| Elderly | 3 |
| Head | 3 |
| Elie | 3 |
| Emergency | 3 |
| English | 3 |
| Epidemic | 3 |
| Estimators | 3 |
| Extension | 3 |
| Freeman | 3 |
| FAST | 3 |
| FULL | 3 |
| Favipiravir | 3 |
| Feldman | 3 |
| Fernandez | 3 |
| Figshare | 3 |
| File | 3 |
| HR | 3 |
| JAMA | 3 |
| Healthy | 3 |
| LIB | 3 |
| Jakobsen | 3 |
| James | 3 |
| Jan | 3 |
| Jun | 3 |
| KRAS | 3 |
| Karnofsky | 3 |
| Kenward | 3 |
| LLC | 3 |
| Holly | 3 |
| Laura | 3 |
| Lauren | 3 |
| Laurence | 3 |
| Leukemia | 3 |
| Liu | 3 |
| Loeb | 3 |
| Editors | 3 |
| Jakarta | 3 |
| JF | 3 |
| Isabelle | 3 |
| Investigator | 3 |
| Hopkins | 3 |
| Hussein | 3 |
| IL-4 | 3 |
| ILI | 3 |
| IQCODE | 3 |
| ISRCTN | 3 |
| ISTp | 3 |
| Implementation | 3 |
| Inclusivity | 3 |
| Independence | 3 |
| Independent | 3 |
| Infectious | 3 |
| Informant | 3 |
| Ingelheim | 3 |
| Ingraham | 3 |
| El | 3 |
| Block | 3 |
| Economics | 3 |
| Baseline | 3 |
| Approach | 3 |
| Audit | 3 |
| Australasian | 3 |
| Australian | 3 |
| B55 | 3 |
| BMC | 3 |
| Barrett | 3 |
| Bayer | 3 |
| Burden | 3 |
| Better | 3 |
| Betty | 3 |
| Bias | 3 |
| Biomedical | 3 |
| Bivalirudin | 3 |
| M3 | 3 |
| Blueprint | 3 |
| Applied | 3 |
| Ann | 3 |
| Analyses | 3 |
| Ali | 3 |
| AA | 3 |
| ACP | 3 |
| ACTT | 3 |
| AHRP | 3 |
| ALK | 3 |
| AS | 3 |
| ASCO | 3 |
| AZD1775 | 3 |
| Abdullah | 3 |
| Abstract | 3 |
| Actelion | 3 |
| Affairs | 3 |
| Ahmad | 3 |
| Air | 3 |
| Akt | 3 |
| Bubo | 3 |
| CHMP | 3 |
| ENT | 3 |
| Daegu | 3 |
| Consent | 3 |
| Consolidated | 3 |
| Controlled | 3 |
| Copenhagen | 3 |
| Crit | 3 |
| Cross | 3 |
| Cyclosporine | 3 |
| Daily | 3 |
| CIOMS | 3 |
| Daniel | 3 |
| Depression | 3 |
| Dexamethasone | 3 |
| Distress | 3 |
| E6 | 3 |
| EEN | 3 |
| EMR | 3 |
| Committees | 3 |
| Cohort | 3 |
| Coalition | 3 |
| CoV2 | 3 |
| COMPARATOR | 3 |
| COSMOS | 3 |
| COVid-19 | 3 |
| CQ | 3 |
| CTA | 3 |
| Canada | 3 |
| Canadian | 3 |
| Cardiovascular | 3 |
| Census | 3 |
| Challenge | 3 |
| Chaturvedi | 3 |
| Chief | 3 |
| Chiesi | 3 |
| Child | 3 |
| CoV-1 | 3 |
| Lucas | 3 |
| B67 | 3 |
| MCRI | 3 |
| Vignette | 3 |
| Tropical | 3 |
| U | 3 |
| UCLA | 3 |
| Understanding | 3 |
| Vaccines | 3 |
| Van | 3 |
| Victorian | 3 |
| WMA | 3 |
| Transl | 3 |
| WMD | 3 |
| Wang | 3 |
| Watzek | 3 |
| Wilcoxon | 3 |
| Windows | 3 |
| York | 3 |
| Yu | 3 |
| Transmission | 3 |
| Trajectories | 3 |
| Service | 3 |
| Straws | 3 |
| Smith | 3 |
| Sophie | 3 |
| Spanish | 3 |
| Speed | 3 |
| Standard | 3 |
| Start | 3 |
| StataCorp | 3 |
| Streptomycin | 3 |
| Timing | 3 |
| Surface | 3 |
| Survey | 3 |
| Sørensen | 3 |
| TWiCS | 3 |
| Technical | 3 |
| Therapeutic | 3 |
| Thoracic | 3 |
| Zhao | 3 |
| Zihui | 3 |
| aids | 3 |
| t4-t5 | 3 |
| pemphigoid | 3 |
| range | 3 |
| red | 3 |
| sciences | 3 |
| series | 3 |
| spray | 3 |
| square | 3 |
| tReated | 3 |
| alpha | 3 |
| thERapY | 3 |
| umifenovir | 3 |
| vaccinees | 3 |
| van | 3 |
| − | 3 |
| | 3 |
| MI | 3 |
| pangolin | 3 |
| novaferon | 3 |
| marboxil | 3 |
| larotrectinib | 3 |
| caf-1 | 3 |
| control | 3 |
| coronavirus-2 | 3 |
| crizotinib | 3 |
| doi | 3 |
| drug | 3 |
| dupilumab | 3 |
| ePhenome | 3 |
| gov | 3 |
| green | 3 |
| https:// | 3 |
| https://doi.org/10.1101/2020.05.30.20117523 | 3 |
| iMac | 3 |
| indacaterol | 3 |
| intErferon | 3 |
| Simón | 3 |
| areata | 3 |
| Sequential | 3 |
| Nguyen | 3 |
| Multicenter | 3 |
| NCT04043364 | 3 |
| NF | 3 |
| NP | 3 |
| Neck | 3 |
| Neonatal | 3 |
| Newcastle | 3 |
| Non | 3 |
| PP | 3 |
| Nordic | 3 |
| ORIGINS | 3 |
| OTH | 3 |
| OUTCOMES | 3 |
| October | 3 |
| Oncol | 3 |
| Orphan | 3 |
| Morrison | 3 |
| Mometasone | 3 |
| Molenberghs | 3 |
| Molecular | 3 |
| MIDI | 3 |
| Scotland | 3 |
| MMF | 3 |
| MTX | 3 |
| MW | 3 |
| MacBook | 3 |
| Marshall | 3 |
| McGuigan | 3 |
| MedImmune | 3 |
| Medicinal | 3 |
| Mental | 3 |
| Method | 3 |
| Mini | 3 |
| Minimum | 3 |
| Mohamed | 3 |
| PO | 3 |
| Moreno | 3 |
| PROSPERO | 3 |
| Roche | 3 |
| Ratitch | 3 |
| Red | 3 |
| Regulations | 3 |
| Relative | 3 |
| Requirements | 3 |
| Riyadh | 3 |
| Robert | 3 |
| Royal | 3 |
| RANDOMISED | 3 |
| Rubio | 3 |
| S. | 3 |
| SARS‐CoV‐2 | 3 |
| SAS | 3 |
| PROTOCOL | 3 |
| SOLIDARITY | 3 |
| Sci | 3 |
| REDCap | 3 |
| Rerup | 3 |
| Pharma | 3 |
| Practices | 3 |
| Parent | 3 |
| R3 | 3 |
| Park | 3 |
| Pearson | 3 |
| Perspective | 3 |
| Placebo | 3 |
| Planning | 3 |
| Plotnik | 3 |
| President | 3 |
| Process | 3 |
| Product | 3 |
| Protections | 3 |
| Qing | 3 |
| Quercetin | 3 |
| PRP | 3 |
| HREC | 2 |
| HHK | 2 |
| HMC | 2 |
| HRA | 2 |
| Graphs | 2 |
| HTA | 2 |
| Haemophilus | 2 |
| H5N1 | 2 |
| Hajj | 2 |
| HCSC | 2 |
| Griffiths | 2 |
| Gorilla | 2 |
| H1N1 | 2 |
| Gyeongsangbuk | 2 |
| Gurmeet | 2 |
| Guidelines | 2 |
| Guangdong | 2 |
| Grasselli | 2 |
| Hamazaki | 2 |
| Halimi | 2 |
| Hospitalized | 2 |
| Haraldsplass | 2 |
| Hochberg | 2 |
| Hu | 2 |
| Glostrup | 2 |
| Hrubesch | 2 |
| Hospitals | 2 |
| Horner | 2 |
| Horby | 2 |
| Hoffman | 2 |
| Hodgkin | 2 |
| High | 2 |
| Hart | 2 |
| Her-2 | 2 |
| Hennink | 2 |
| Heart | 2 |
| Headquarters | 2 |
| Hb | 2 |
| Haun | 2 |
| Hassan | 2 |
| Harvard | 2 |
| Goldfeld | 2 |
| Eur | 2 |
| Gleevec | 2 |
| Evidence | 2 |
| FEV1 | 2 |
| FDR | 2 |
| FAIR | 2 |
| F1 | 2 |
| Exp | 2 |
| Excel | 2 |
| Examination | 2 |
| Evolution | 2 |
| Event | 2 |
| Facilitation | 2 |
| Eva | 2 |
| EusaPharma | 2 |
| Ethical | 2 |
| Etheredge | 2 |
| Española | 2 |
| Erik | 2 |
| Epidemiol | 2 |
| Hypoglycaemia | 2 |
| FS | 2 |
| Failure | 2 |
| Glasgow | 2 |
| Francesca | 2 |
| Gabriel | 2 |
| GOLD | 2 |
| GM | 2 |
| GF | 2 |
| Functional | 2 |
| Fudan | 2 |
| Franklin | 2 |
| Francisco | 2 |
| Force | 2 |
| Farber | 2 |
| Flow | 2 |
| Fiona | 2 |
| Finland | 2 |
| Fernandes | 2 |
| Feigenson | 2 |
| Fei | 2 |
| Federica | 2 |
| Fatigue | 2 |
| Hygiene | 2 |
| Label | 2 |
| ICF | 2 |
| Kaiser | 2 |
| King | 2 |
| Kindle | 2 |
| Kim | 2 |
| Kilwinning | 2 |
| Kentucky | 2 |
| Kendall | 2 |
| Keith | 2 |
| Kanchanaburi | 2 |
| KJR | 2 |
| Koopman | 2 |
| KEYNOTE-001 | 2 |
| KC | 2 |
| K+ | 2 |
| Julie | 2 |
| Julia | 2 |
| Josefin | 2 |
| Jordan | 2 |
| Jingcheng | 2 |
| Knowledge | 2 |
| Korean | 2 |
| Jean | 2 |
| Lambeth | 2 |
| Library | 2 |
| Liberia | 2 |
| Letter | 2 |
| Leone | 2 |
| Legare | 2 |
| Le | 2 |
| Laurie | 2 |
| Lars | 2 |
| Enterprise | 2 |
| L1 | 2 |
| Lab | 2 |
| LSG | 2 |
| LOESS | 2 |
| LMWH | 2 |
| LM | 2 |
| LIVING | 2 |
| LIBERTY | 2 |
| LDH | 2 |
| Jeremy | 2 |
| Jazz | 2 |
| ICUs | 2 |
| IRCT20200405046958N1 | 2 |
| Individual | 2 |
| Indians | 2 |
| Improvisation | 2 |
| Immunosuppression | 2 |
| Immunoglobulin | 2 |
| IU | 2 |
| ITTI | 2 |
| ITCC | 2 |
| IRCT | 2 |
| Industry | 2 |
| IPTW | 2 |
| IPD | 2 |
| IND | 2 |
| IMI | 2 |
| IMASOY | 2 |
| IL-1 | 2 |
| IL | 2 |
| IEC | 2 |
| Indonesia | 2 |
| Inference | 2 |
| Janus | 2 |
| Introduction- | 2 |
| Jaeger | 2 |
| JCJ | 2 |
| JB | 2 |
| J.D.D. | 2 |
| Issues | 2 |
| Isfahan | 2 |
| Investigational | 2 |
| Investigation | 2 |
| Interventional | 2 |
| Informal | 2 |
| Internal | 2 |
| Intern | 2 |
| Interferon | 2 |
| Intensive | 2 |
| Integrity | 2 |
| Integrated | 2 |
| Instruments | 2 |
| Insects | 2 |
| Environment | 2 |
| Carolina | 2 |
| Ensemble | 2 |
| Assumptions | 2 |
| B92 | 2 |
| B19 | 2 |
| B17 | 2 |
| B119 | 2 |
| B109 | 2 |
| B. | 2 |
| Avdagic | 2 |
| AustralaSian | 2 |
| Article | 2 |
| BC | 2 |
| Arthur | 2 |
| Art | 2 |
| Arnaud | 2 |
| Arjun | 2 |
| Arbidol | 2 |
| Appropriation | 2 |
| Apple | 2 |
| Anticoagulation | 2 |
| BBB | 2 |
| BMI | 2 |
| Animal | 2 |
| Ben | 2 |
| Bruno | 2 |
| Bourdin | 2 |
| Born | 2 |
| Bonferroni | 2 |
| Blinded | 2 |
| Biobank | 2 |
| Bhattacherjee | 2 |
| Benelux | 2 |
| Behaviour | 2 |
| BSH | 2 |
| Behavioral | 2 |
| Beecher | 2 |
| Bauer | 2 |
| Based | 2 |
| Baojun | 2 |
| Baldotto_Clarissa | 2 |
| Baillargeon | 2 |
| BTs | 2 |
| Anne | 2 |
| Andrea | 2 |
| Enhancement | 2 |
| AG | 2 |
| ASCOT | 2 |
| APTT | 2 |
| APC | 2 |
| APA | 2 |
| ANTI | 2 |
| ALVEOLI | 2 |
| AIFA | 2 |
| AIDS | 2 |
| ACTIV | 2 |
| AUD | 2 |
| ACIS | 2 |
| 5d | 2 |
| 500mg | 2 |
| 3- | 2 |
| 1C | 2 |
| -July | 2 |
| -August | 2 |
| Lifecourse | 2 |
| AUC | 2 |
| Aboriginal | 2 |
| Ana | 2 |
| Agitation | 2 |
| Amin | 2 |
| Ameer | 2 |
| Alison | 2 |
| Alireza | 2 |
| Alba | 2 |
| Airway | 2 |
| Ahmed | 2 |
| Agreement | 2 |
| Advisors | 2 |
| Abraham | 2 |
| Adjuvant | 2 |
| Adjustment | 2 |
| Adjusted | 2 |
| Adjunctive | 2 |
| Adalimumab | 2 |
| Accessibility | 2 |
| Acceptance | 2 |
| Abrar | 2 |
| Bu | 2 |
| Bubonic | 2 |
| C1-C9 | 2 |
| Dakota | 2 |
| Deputy | 2 |
| Dennis | 2 |
| Democratic | 2 |
| Delphi | 2 |
| Decline | 2 |
| Deborah | 2 |
| Deaconess | 2 |
| Davidson | 2 |
| DRC | 2 |
| Diagnosis | 2 |
| DPIA | 2 |
| DOASS | 2 |
| DJC | 2 |
| DIS | 2 |
| DC | 2 |
| D'Arcy | 2 |
| Cyclosporin | 2 |
| Curcumin | 2 |
| Devices | 2 |
| Dignity | 2 |
| CKJ | 2 |
| EUA | 2 |
| Emily | 2 |
| Elements | 2 |
| Electronic | 2 |
| Eklöf | 2 |
| Effects | 2 |
| Eddy | 2 |
| Economy | 2 |
| EVD | 2 |
| ETF | 2 |
| Dong | 2 |
| ESMO | 2 |
| ERP | 2 |
| EQ-5D | 2 |
| ECRIN | 2 |
| EB | 2 |
| E. | 2 |
| Duffett | 2 |
| Du | 2 |
| Creactive | 2 |
| Cosaque | 2 |
| Cornell | 2 |
| Carpenter | 2 |
| Checklist | 2 |
| Charmaz | 2 |
| Charlotte | 2 |
| Chanez | 2 |
| Chancellor | 2 |
| Centered | 2 |
| Celgene | 2 |
| Cañete | 2 |
| Carol | 2 |
| Copyright | 2 |
| Carey | 2 |
| CVD03-HgR | 2 |
| CRM | 2 |
| CPMs | 2 |
| COVID- | 2 |
| COV2 | 2 |
| CML | 2 |
| CLSI | 2 |
| Chemotherapy | 2 |
| Choudrie | 2 |
| Chowdhery | 2 |
| Chughtai | 2 |
| Context | 2 |
| Contamination | 2 |
| Consortium | 2 |
| Consensus | 2 |
| Consensi | 2 |
| Congo | 2 |
| Computing | 2 |
| Comprehensive | 2 |
| Comparison | 2 |
| Company | 2 |
| Commercial | 2 |
| Comité | 2 |
| Collaborative | 2 |
| Cognitive | 2 |
| Cmax | 2 |
| ClinicalTrials | 2 |
| Classification | 2 |
| License | 2 |
| BYOD | 2 |
| Limited | 2 |
| TX | 2 |
| Tian | 2 |
| Thu | 2 |
| Thomas | 2 |
| Third | 2 |
| Th17 | 2 |
| Task | 2 |
| Tams | 2 |
| Tables | 2 |
| TSH | 2 |
| Times | 2 |
| TPP | 2 |
| TNW | 2 |
| TNFalpha | 2 |
| TIDieR | 2 |
| Swiss | 2 |
| Sweden | 2 |
| Swann | 2 |
| Swan | 2 |
| Tignanelli | 2 |
| Together | 2 |
| Summary | 2 |
| VA | 2 |
| Volunteer | 2 |
| Volkoff | 2 |
| Viscum | 2 |
| Vienna | 2 |
| Vice | 2 |
| Veterinary | 2 |
| Veterans | 2 |
| Value | 2 |
| Utrecht | 2 |
| Tor | 2 |
| Utilisation | 2 |
| UFT | 2 |
| Tyne | 2 |
| 2 | |
| TwiCs | 2 |
| Tuskegee | 2 |
| Triple | 2 |
| Torres | 2 |
| Sustainability | 2 |
| Suehs | 2 |
| Wake | 2 |
| Safes | 2 |
| Sensitivity | 2 |
| Sedrakyan | 2 |
| Scholar | 2 |
| Scheiner | 2 |
| Schapiro | 2 |
| Scandinavia | 2 |
| Sara | 2 |
| Saffery | 2 |
| SUSAR | 2 |
| Shirahada | 2 |
| STEMI | 2 |
| STATA | 2 |
| SSG | 2 |
| SPSS | 2 |
| SP | 2 |
| SMART | 2 |
| SLE | 2 |
| SJ | 2 |
| Sepsis | 2 |
| Short | 2 |
| Sud | 2 |
| Stata | 2 |
| Stæhr | 2 |
| Streamlined | 2 |
| Strait | 2 |
| Stomach | 2 |
| Stevens | 2 |
| Stefan | 2 |
| Statistics | 2 |
| Station | 2 |
| Stahl | 2 |
| Shuming | 2 |
| Sponsor | 2 |
| Solutions | 2 |
| Software | 2 |
| Singapore | 2 |
| Sinai | 2 |
| Sierra | 2 |
| Sidney | 2 |
| Siddiqui | 2 |
| W. | 2 |
| Walsham | 2 |
| SEFAS | 2 |
| ki | 2 |
| n= | 2 |
| ms | 2 |
| methylprednisolone | 2 |
| maximus | 2 |
| mSv | 2 |
| mHealth | 2 |
| los | 2 |
| lme4 | 2 |
| key | 2 |
| nasendoscopy | 2 |
| ixekizumab | 2 |
| ivermectin | 2 |
| iCAT_SR | 2 |
| https://doi.org/10.1038/s41598-020-65898-x | 2 |
| homecare | 2 |
| europa | 2 |
| eu/ | 2 |
| ethics | 2 |
| n=51 | 2 |
| nonexperimental | 2 |
| el | 2 |
| social | 2 |
| Lingwen | 2 |
| × | 2 |
| À.63 | 2 |
| À | 2 |
| www.nature.com/scientificreports | 2 |
| subgroup | 2 |
| streptomycin | 2 |
| st | 2 |
| sildenafil | 2 |
| nonmaleficence | 2 |
| sequalae | 2 |
| septorhinoplasty | 2 |
| scan | 2 |
| sarilumab | 2 |
| requirement(s | 2 |
| preprint | 2 |
| piperaquine | 2 |
| 2 | |
| en | 2 |
| ec | 2 |
| 2 | |
| Yijie | 2 |
| anakinra | 2 |
| alopecia | 2 |
| ZMapp | 2 |
| ZEBOV | 2 |
| Z | 2 |
| Yubao | 2 |
| Ying | 2 |
| Yin | 2 |
| Xue | 2 |
| ance | 2 |
| Xa | 2 |
| Wyatt | 2 |
| Wright | 2 |
| Workers | 2 |
| WordPress | 2 |
| Word | 2 |
| Wildlife | 2 |
| Wenqian | 2 |
| analysis | 2 |
| antiXa | 2 |
| disease-2019 | 2 |
| cobicistat | 2 |
| dinutuximab | 2 |
| des | 2 |
| del | 2 |
| data | 2 |
| creativecommons | 2 |
| covid19 | 2 |
| covid-19 | 2 |
| colchicine | 2 |
| clin | 2 |
| appendix | 2 |
| clarithromycin | 2 |
| calfactant | 2 |
| bullous | 2 |
| bubo | 2 |
| beta-1b | 2 |
| beta-1a | 2 |
| baloxavir | 2 |
| author(s | 2 |
| SIOPEN | 2 |
| Yersinia | 2 |
| SC | 2 |
| Muller | 2 |
| Nasrallah | 2 |
| Naseptin | 2 |
| NYT | 2 |
| NR3 | 2 |
| NAT | 2 |
| N. | 2 |
| Méditerranée | 2 |
| Mycophenolate | 2 |
| Mount | 2 |
| Nebraska | 2 |
| Monitor | 2 |
| Mohammad | 2 |
| Models | 2 |
| Modeling | 2 |
| Mobilization | 2 |
| Mobile | 2 |
| Mo | 2 |
| Misinformation | 2 |
| Natalie | 2 |
| Networking | 2 |
| MiPL | 2 |
| Oliver | 2 |
| Otolaryngol | 2 |
| Oseltamivir | 2 |
| Orlikowski | 2 |
| Organisation | 2 |
| Organ | 2 |
| Operations | 2 |
| Operational | 2 |
| Omalizumab | 2 |
| Ohio | 2 |
| Neuropsychiatric | 2 |
| Official | 2 |
| Observational | 2 |
| Observation | 2 |
| Nursing | 2 |
| Notch-1 | 2 |
| None | 2 |
| Nicolas | 2 |
| Nicholas | 2 |
| Mike | 2 |
| Meyer | 2 |
| Outbreaks | 2 |
| Lynch | 2 |
| MHV | 2 |
| MHRA | 2 |
| MDP | 2 |
| MDA | 2 |
| MCID | 2 |
| MCF-7 | 2 |
| MB-231 | 2 |
| Lyytinen | 2 |
| Lv | 2 |
| MR | 2 |
| Luminex | 2 |
| Luce | 2 |
| Longitudinal | 2 |
| Long | 2 |
| Lombardy | 2 |
| SAMMPRIS | 2 |
| Livestock | 2 |
| Living | 2 |
| MOBID | 2 |
| MRI | 2 |
| Methods | 2 |
| Market | 2 |
| Merck | 2 |
| Medication | 2 |
| Mean | 2 |
| McGann | 2 |
| McCulloch | 2 |
| Material | 2 |
| Massachusetts | 2 |
| Martin | 2 |
| Mark | 2 |
| MV | 2 |
| Marignane | 2 |
| Marco | 2 |
| Mansfield | 2 |
| Mallinckrodt | 2 |
| Malawi | 2 |
| Malaria | 2 |
| Mahidol | 2 |
| Mac | 2 |
| Outbreak | 2 |
| Methodology | 2 |
| Ovid | 2 |
| Prism | 2 |
| Region | 2 |
| Reducing | 2 |
| Recovery | 2 |
| Rebecca | 2 |
| Ray | 2 |
| Rating | 2 |
| RECOVERY | 2 |
| RD | 2 |
| RANDOMISATION | 2 |
| Quintet | 2 |
| Qualtrics | 2 |
| Qatar | 2 |
| QTc | 2 |
| QT | 2 |
| QALY | 2 |
| Q1-Q3 | 2 |
| Psychiatry | 2 |
| Programme | 2 |
| Processes | 2 |
| Replication | 2 |
| Res | 2 |
| ResMan | 2 |
| Roundup | 2 |
| SAMIT | 2 |
| S13 | 2 |
| S12 | 2 |
| PCAST | 2 |
| S11 | 2 |
| S-1 | 2 |
| Rule | 2 |
| Rozina | 2 |
| Rossi | 2 |
| Reserve | 2 |
| Ross | 2 |
| Ronald | 2 |
| Road | 2 |
| RoB | 2 |
| Ring | 2 |
| Riemer | 2 |
| Richard | 2 |
| Resveratrol | 2 |
| Problem | 2 |
| Rep | 2 |
| Presence | 2 |
| PaO2 | 2 |
| Performance | 2 |
| Pattern | 2 |
| Pascal | 2 |
| Parliament | 2 |
| Pankaj | 2 |
| Pandemics | 2 |
| Pallud | 2 |
| Paediatric | 2 |
| PROTOACCEPT | 2 |
| Personnes | 2 |
| PPE | 2 |
| PIONEER | 2 |
| PHP | 2 |
| Preparedness | 2 |
| PEs | 2 |
| PCORI | 2 |
| PDE4 | 2 |
| PD | 2 |
| Permanente | 2 |
| Pangolin | 2 |
| Population | 2 |
| Points | 2 |
| Prednisone | 2 |
| Precision | 2 |
| Pharmacol | 2 |
| Practical | 2 |
| Potential | 2 |
| Portal | 2 |
| Porphyria | 2 |
| Premkumar | 2 |
| Pongo | 2 |
| Pregnancy | 2 |
| Pneumonia | 2 |
| Pierre | 2 |
| PhenX | 2 |
| Pheromone | 2 |
| Philippe | 2 |
| Plans | 2 |
| Plasma | 2 |
| Heaton | 1 |
| Healthstar | 1 |
| Heather | 1 |
| Hazzard | 1 |
| Hazards | 1 |
| Hazard | 1 |
| Hayden | 1 |
| Harald | 1 |
| Hayley | 1 |
| Harbi | 1 |
| Harmonised | 1 |
| Haug | 1 |
| Hatch | 1 |
| HasanAbadi | 1 |
| Harwood | 1 |
| Harthy | 1 |
| Harrison | 1 |
| Harmonation | 1 |
| Hargreaves | 1 |
| Hekkala | 1 |
| Harborough | 1 |
| Hein | 1 |
| Hillestad | 1 |
| Helen | 1 |
| Highlands | 1 |
| Hirsch | 1 |
| Hanson | 1 |
| Historical | 1 |
| Hitchings | 1 |
| Hindex | 1 |
| Himba | 1 |
| Himalayas | 1 |
| Hillerød | 1 |
| Hillary | 1 |
| Hill | 1 |
| Hierarchy | 1 |
| Hell | 1 |
| Hidle | 1 |
| Heumann | 1 |
| Heterogeneous | 1 |
| Heterogeneity | 1 |
| Hermina | 1 |
| Herlev | 1 |
| Heparin | 1 |
| Hepach | 1 |
| Henry | 1 |
| Helskinki | 1 |
| Hans‐Georg | 1 |
| Guilherme | 1 |
| Hansen | 1 |
| Gyeonggi | 1 |
| HER2 | 1 |
| HEALTHCARE | 1 |
| HCl | 1 |
| H1N1pdm09 | 1 |
| H1N109 | 1 |
| H1N1(09 | 1 |
| H | 1 |
| Gönül | 1 |
| Gökçen | 1 |
| Gynecologic | 1 |
| Guillaume | 1 |
| Hanko | 1 |
| Guillain | 1 |
| Guido | 1 |
| Guiding | 1 |
| Guerra | 1 |
| Guardian | 1 |
| Guard | 1 |
| Grupo | 1 |
| Hladun | 1 |
| Grolleau | 1 |
| Griffith | 1 |
| HFpEF | 1 |
| HIF-1α | 1 |
| HIN1 | 1 |
| HIN1(09 | 1 |
| Hani | 1 |
| Hanel | 1 |
| Hanan | 1 |
| Hamza | 1 |
| Hamilton | 1 |
| Hameed | 1 |
| Hamad | 1 |
| Halloran | 1 |
| Hale | 1 |
| Hague | 1 |
| Haenszel | 1 |
| Haemostasis | 1 |
| Haematology | 1 |
| Haddy | 1 |
| Hackman | 1 |
| Hacid | 1 |
| HW | 1 |
| HTA)-funded | 1 |
| HMO | 1 |
| HMGH | 1 |
| HITECH | 1 |
| Hjorthøj | 1 |
| Illustrators | 1 |
| Hodgson | 1 |
| IL‐12 | 1 |
| IU/20 | 1 |
| IS | 1 |
| IRB)-Independent | 1 |
| IR.MUMS.REC.1399.078 | 1 |
| IQR114 | 1 |
| IOIS | 1 |
| IMPACT | 1 |
| IML | 1 |
| IL‐4/13 | 1 |
| IL‐17 | 1 |
| IL-8 | 1 |
| IECs | 1 |
| IL-22 | 1 |
| IL-2 | 1 |
| IL-1b | 1 |
| IL-17-dependent | 1 |
| IL-17-deficient | 1 |
| IL-13 | 1 |
| IL-12p40 | 1 |
| IL-12/23p40 | 1 |
| IL-12/23 | 1 |
| IIa | 1 |
| IUCN | 1 |
| IVIG | 1 |
| IX | 1 |
| Ian | 1 |
| Gregory | 1 |
| Indicators | 1 |
| Index | 1 |
| Indemnity | 1 |
| Inc | 1 |
| Inaba | 1 |
| InSPiRe | 1 |
| Improved | 1 |
| Impression | 1 |
| Imperial | 1 |
| Immunomodulatory | 1 |
| Immunol | 1 |
| Immortal | 1 |
| Imatinib | 1 |
| Imani | 1 |
| Illness | 1 |
| Ill | 1 |
| Ignacio | 1 |
| IgE | 1 |
| Iden | 1 |
| Idelalisib | 1 |
| IFN)-c | 1 |
| IDeAl | 1 |
| Hohenberger | 1 |
| Hovav | 1 |
| Huguet_Francoise | 1 |
| Huguet | 1 |
| Hughes | 1 |
| Hudry | 1 |
| Huberman | 1 |
| Huarui | 1 |
| Hróbjartsson | 1 |
| Howraman | 1 |
| Howel | 1 |
| Howard | 1 |
| Houshang | 1 |
| ICS | 1 |
| Hossein | 1 |
| Hospitalier | 1 |
| Hormozd | 1 |
| Hookway | 1 |
| Honiara | 1 |
| Hong | 1 |
| Holtz | 1 |
| Holstein | 1 |
| Holland | 1 |
| Hohlfeld | 1 |
| Hui | 1 |
| Humbert | 1 |
| Hunter | 1 |
| Huo | 1 |
| ICMRA | 1 |
| ICIS | 1 |
| ICD-11 | 1 |
| IBM | 1 |
| I.M.C. | 1 |
| Håkansson | 1 |
| Hyponatraemia | 1 |
| Hypokalaemia | 1 |
| Hypersensitivity | 1 |
| Hyperprogressive | 1 |
| Hypernatremia | 1 |
| Hyperkalaemia | 1 |
| Hyperglycaemia | 1 |
| Hyperchloremia | 1 |
| Hynes | 1 |
| Hyeikyoung | 1 |
| HydroxyChloroquine | 1 |
| Hvidovre | 1 |
| Hutchins | 1 |
| Husebo | 1 |
| Hurricane | 1 |
| Greve | 1 |
| EudraLex | 1 |
| Greer | 1 |
| Faraj | 1 |
| Fed | 1 |
| Febuxostat | 1 |
| Feb | 1 |
| Fatehi | 1 |
| Faso | 1 |
| Farrar | 1 |
| Farran | 1 |
| Farouk | 1 |
| Farmaco | 1 |
| Fargen | 1 |
| Fanlong | 1 |
| Fit | 1 |
| Familiarisation | 1 |
| Faiza | 1 |
| Faisal | 1 |
| Fahey | 1 |
| Fahad | 1 |
| Fagot | 1 |
| Fadnes | 1 |
| Faculty | 1 |
| Facetime | 1 |
| 1 | |
| Federation | 1 |
| Fehizoro | 1 |
| Feinberg | 1 |
| Felix | 1 |
| First | 1 |
| Fiorella | 1 |
| Findability | 1 |
| Final | 1 |
| Filip | 1 |
| Figs | 1 |
| Fiction | 1 |
| FiO2 | 1 |
| FiO | 1 |
| Fezeu | 1 |
| Fever | 1 |
| Ferrand | 1 |
| Feron | 1 |
| Fernández | 1 |
| Fernyhough | 1 |
| Fergus | 1 |
| Feras | 1 |
| Feno | 1 |
| Feng | 1 |
| Fellowship | 1 |
| Feller | 1 |
| Fabri | 1 |
| FVC | 1 |
| FTEs | 1 |
| Essai | 1 |
| Escherichia | 1 |
| Error | 1 |
| Ernest | 1 |
| Erin | 1 |
| Erich | 1 |
| Eric | 1 |
| Eran | 1 |
| Equity | 1 |
| Equipment | 1 |
| EqualContrib | 1 |
| Epimedy | 1 |
| Eosinophilia | 1 |
| Enzmann | 1 |
| Enya | 1 |
| Environmental | 1 |
| Enhancing | 1 |
| Englert | 1 |
| Endpoints | 1 |
| End | 1 |
| Empiricist | 1 |
| Empirical | 1 |
| Eslami | 1 |
| Establishment | 1 |
| FR | 1 |
| Estimating | 1 |
| FOCA | 1 |
| FO | 1 |
| FGH | 1 |
| FEV | 1 |
| FC | 1 |
| FB | 1 |
| FAS | 1 |
| FA | 1 |
| Extract | 1 |
| Exploratory | 1 |
| Explor | 1 |
| Exacerbation | 1 |
| Evrenoglou | 1 |
| Everardo | 1 |
| Evaluability | 1 |
| Eusa | 1 |
| Eureka | 1 |
| Eugene | 1 |
| Infected | 1 |
| Etemad | 1 |
| Estimation | 1 |
| Fishers | 1 |
| Five | 1 |
| Green | 1 |
| Gerontopsychiatric | 1 |
| Gilles | 1 |
| Gillen | 1 |
| Giaglis | 1 |
| Giacomo | 1 |
| Ghosn | 1 |
| Ghazawi | 1 |
| Ghazal | 1 |
| Ghanizada | 1 |
| Ghaleb | 1 |
| Ghaem | 1 |
| Geriatric | 1 |
| Fleischner | 1 |
| Geographical | 1 |
| Geneva | 1 |
| Genentech | 1 |
| Gene | 1 |
| Gender | 1 |
| GenVcollected | 1 |
| Gellsinger | 1 |
| Gedde | 1 |
| Gash | 1 |
| Garrison | 1 |
| Gillesen | 1 |
| Gini | 1 |
| Gitte | 1 |
| Giulia | 1 |
| Graña | 1 |
| Granulomatosis | 1 |
| Granule | 1 |
| Grandma | 1 |
| Grand | 1 |
| Graff | 1 |
| Graduates | 1 |
| Grading | 1 |
| Grabitz | 1 |
| Gowers | 1 |
| Governance | 1 |
| Gottlieb | 1 |
| Goods | 1 |
| Goodman | 1 |
| Gong | 1 |
| Gold | 1 |
| Gobet | 1 |
| Go | 1 |
| Gluud | 1 |
| Glossary | 1 |
| Giuseppe | 1 |
| García | 1 |
| Gandini | 1 |
| Gamez | 1 |
| Frederick | 1 |
| Fraser | 1 |
| François | 1 |
| Francoise | 1 |
| Frances | 1 |
| Fragmented | 1 |
| Fowler | 1 |
| Fouweather | 1 |
| Foundations | 1 |
| Fouet | 1 |
| Forward | 1 |
| Fortina | 1 |
| Forms | 1 |
| Formosan | 1 |
| Formal | 1 |
| Forecasts | 1 |
| Focus | 1 |
| Flynn | 1 |
| FluCAN | 1 |
| Florida | 1 |
| Fletcher | 1 |
| Fleming | 1 |
| Fraud | 1 |
| Frederickson | 1 |
| Gamana | 1 |
| Fremont | 1 |
| Galapagos | 1 |
| Gaborit | 1 |
| GT | 1 |
| GRECCO-19 | 1 |
| GPs | 1 |
| GOLG | 1 |
| GMP | 1 |
| GMOs | 1 |
| GDS | 1 |
| GC | 1 |
| Fæø | 1 |
| Fyfe | 1 |
| Fuzheng | 1 |
| Future | 1 |
| Furman | 1 |
| Functioning | 1 |
| Fulminant | 1 |
| Frøydis | 1 |
| Frode | 1 |
| Fris | 1 |
| Friede | 1 |
| Inf | 1 |
| Korica | 1 |
| Inferno | 1 |
| Ltd. | 1 |
| MACRO | 1 |
| M.Y. | 1 |
| Lyons | 1 |
| Lynn | 1 |
| Lymphoid | 1 |
| Lydia | 1 |
| Luxembourg | 1 |
| Lundgren | 1 |
| Luchetti | 1 |
| Luca | 1 |
| Ltd | 1 |
| Little | 1 |
| Low | 1 |
| Louisiana | 1 |
| Loubna | 1 |
| Lorusso | 1 |
| Longini | 1 |
| Logit | 1 |
| Loehr | 1 |
| Local | 1 |
| Lloyd | 1 |
| Liver | 1 |
| MAMS | 1 |
| MAP | 1 |
| MBSR | 1 |
| MDS | 1 |
| MacIntyre | 1 |
| Maarja | 1 |
| MRC-05 | 1 |
| MRC | 1 |
| MP | 1 |
| MMRM | 1 |
| ML | 1 |
| MIR | 1 |
| MIP-1a | 1 |
| MIND | 1 |
| MINC | 1 |
| MHV-3 | 1 |
| MHG | 1 |
| MH | 1 |
| MF | 1 |
| METOP | 1 |
| MET | 1 |
| MESIFOS | 1 |
| MEH | 1 |
| MEC | 1 |
| MDs | 1 |
| LiveJournal | 1 |
| Literature | 1 |
| Lance | 1 |
| Lausanne | 1 |
| Lehana | 1 |
| Legrand | 1 |
| Lee | 1 |
| Led | 1 |
| Leah | 1 |
| Leadership | 1 |
| Leaders | 1 |
| Lazio | 1 |
| Laws | 1 |
| Lawrence | 1 |
| Laursen | 1 |
| Lisbeth | 1 |
| Laufer | 1 |
| Lasciate | 1 |
| Larson | 1 |
| Larotrectinib | 1 |
| Largent | 1 |
| Large | 1 |
| Lapperre | 1 |
| Lapointe | 1 |
| Laplace | 1 |
| Langerak | 1 |
| Lei | 1 |
| Leila | 1 |
| Lenz | 1 |
| Leon | 1 |
| Lipocurc | 1 |
| Linux | 1 |
| Linnaeus | 1 |
| Line | 1 |
| Linderoth | 1 |
| Lindegaard | 1 |
| Lincoln | 1 |
| Lincocin | 1 |
| Lina | 1 |
| Lim | 1 |
| Light | 1 |
| Libron | 1 |
| Libray | 1 |
| Liang | 1 |
| Levina | 1 |
| Leukin | 1 |
| Lessons | 1 |
| Leslie | 1 |
| Lesaffre | 1 |
| Leopold | 1 |
| Leonardi | 1 |
| Macbook | 1 |
| Macomber | 1 |
| Maculopathy | 1 |
| Mayouya | 1 |
| Meade | 1 |
| MeSH | 1 |
| MeNTS | 1 |
| McNicholas | 1 |
| McLin | 1 |
| McLeod | 1 |
| McHugh | 1 |
| McFadden | 1 |
| Mazzarella | 1 |
| Mazwi | 1 |
| Maymunah | 1 |
| Madewell | 1 |
| Mavuto | 1 |
| Mavridis | 1 |
| Maurizio | 1 |
| Mauricia | 1 |
| Matthieu | 1 |
| Matthias | 1 |
| Matthews | 1 |
| Matt | 1 |
| Mathilde | 1 |
| Mathanga | 1 |
| Measles | 1 |
| Measurement | 1 |
| Measures | 1 |
| Meat | 1 |
| Meredith | 1 |
| Merchant | 1 |
| Memish | 1 |
| Members | 1 |
| Member | 1 |
| Melvin | 1 |
| Mellitus | 1 |
| Melbourne | 1 |
| Melanoma | 1 |
| Mekhlafi | 1 |
| Meier | 1 |
| Meguerditchian | 1 |
| Megan | 1 |
| Meeting | 1 |
| Meerpohl | 1 |
| Mediterranean | 1 |
| Medidas | 1 |
| Medicamentos | 1 |
| MedRxiv | 1 |
| Mechanism | 1 |
| Mechanical | 1 |
| Maternal | 1 |
| Materials | 1 |
| Matching | 1 |
| Manufacturers | 1 |
| Mannseth | 1 |
| Manidae | 1 |
| Mangahasimbola | 1 |
| Mandourah | 1 |
| Manager | 1 |
| Mamy | 1 |
| Mammalia | 1 |
| Mammal | 1 |
| Malty | 1 |
| Malik | 1 |
| Malar | 1 |
| Mala | 1 |
| Majid | 1 |
| Majed | 1 |
| MainStage | 1 |
| Mahillo | 1 |
| Magpix | 1 |
| Magni | 1 |
| Maechler | 1 |
| Mady | 1 |
| Madsen | 1 |
| Mantel | 1 |
| Manufacturing | 1 |
| Mass | 1 |
| Mao | 1 |
| Mask | 1 |
| Marusich | 1 |
| Martínez | 1 |
| Martinsons | 1 |
| Marseille | 1 |
| Marraro | 1 |
| Marnoch | 1 |
| Marinus | 1 |
| Marinette | 1 |
| Maria | 1 |
| Margie | 1 |
| Marcus | 1 |
| Marcovitch | 1 |
| Marciano | 1 |
| Marchenko | 1 |
| March-12th | 1 |
| Marcel | 1 |
| Marc | 1 |
| Marboxil | 1 |
| Map1-LC3b | 1 |
| Map | 1 |
| Landscape | 1 |
| Lalitpur | 1 |
| Inflexibility | 1 |
| Jabbar | 1 |
| JavaScript | 1 |
| Jasperson | 1 |
| Jasper | 1 |
| Japanese | 1 |
| Janner | 1 |
| Janne | 1 |
| Janet | 1 |
| Jane | 1 |
| Jaffuel | 1 |
| Jacobsen | 1 |
| JWBY)-Bushen | 1 |
| Islands | 1 |
| JRCT | 1 |
| JPD | 1 |
| JP | 1 |
| JL | 1 |
| JAW | 1 |
| J.L.W.Reprints | 1 |
| J.L. | 1 |
| Ivy | 1 |
| Ivan | 1 |
| Italiana | 1 |
| Jeffrey | 1 |
| Jehovah | 1 |
| Jeon | 1 |
| Jeraisy | 1 |
| Jonsson | 1 |
| Jones | 1 |
| Jonathan | 1 |
| Jon | 1 |
| Jokhdar | 1 |
| Joint | 1 |
| Johnston | 1 |
| Johns | 1 |
| Joerg | 1 |
| Jodacare | 1 |
| Joal | 1 |
| Jin | 1 |
| Jie | 1 |
| Jicha | 1 |
| Jiangsu | 1 |
| Jessika | 1 |
| Jessica | 1 |
| Jesse | 1 |
| Jess | 1 |
| Jesna | 1 |
| Jerome | 1 |
| Israel | 1 |
| Islander | 1 |
| Laird | 1 |
| Innovative | 1 |
| Interdependence | 1 |
| Interactive | 1 |
| Inter | 1 |
| Intensity | 1 |
| Integr | 1 |
| Institut | 1 |
| Instillation | 1 |
| Inspiratory | 1 |
| Insitute | 1 |
| Insect | 1 |
| Innovations | 1 |
| Island | 1 |
| Injury | 1 |
| Injuries | 1 |
| Injection | 1 |
| Inhibitors | 1 |
| Inhibition | 1 |
| Ingi | 1 |
| Ingeheim | 1 |
| Infrastructure | 1 |
| Informativeness | 1 |
| Infliximab | 1 |
| Interdisciplinary | 1 |
| Intergrating | 1 |
| Interim | 1 |
| Interleukin-1 | 1 |
| Irish | 1 |
| Ira | 1 |
| Ipsit | 1 |
| Ipilimumab | 1 |
| Ipads | 1 |
| Iowa | 1 |
| Ionescu | 1 |
| Inès | 1 |
| Involvement | 1 |
| Investigations | 1 |
| Inverse | 1 |
| Intravenous | 1 |
| Intra | 1 |
| Interval | 1 |
| Interv | 1 |
| Interrupted | 1 |
| Interrater | 1 |
| Interpretability | 1 |
| Interoperability | 1 |
| Intermittent | 1 |
| Interleukin-6 | 1 |
| Joondalup | 1 |
| Joost | 1 |
| Jose | 1 |
| Kjell | 1 |
| Krag | 1 |
| Kotsimbos | 1 |
| Emmanuel | 1 |
| Komarek | 1 |
| Kojan | 1 |
| Knottnerus | 1 |
| Knop | 1 |
| Klingenberg | 1 |
| Kjome | 1 |
| Kjerstad | 1 |
| Kirsten | 1 |
| Joseph | 1 |
| Kirkham | 1 |
| Kirkevold | 1 |
| Kirchhof | 1 |
| Kirby | 1 |
| Kiran | 1 |
| Kineret | 1 |
| Kieser | 1 |
| Kidney | 1 |
| Ki67 | 1 |
| Khatami | 1 |
| Kristian | 1 |
| Kristin | 1 |
| Kristine | 1 |
| Krokeide | 1 |
| Laffey | 1 |
| Laboratorybased | 1 |
| Laboratory | 1 |
| La | 1 |
| LT | 1 |
| LRTI | 1 |
| LR | 1 |
| LMH | 1 |
| LIVE@Home.-Path | 1 |